Oxford Capital Partners has announced its investment in OrthoMimetics Limited, the first technology spin-out from the Cambridge-MIT Institute (CMI). Oxford Capital Partners joins a syndicate of investors including Schroders Investment Management Ltd, Sloane Robinson Private Equity and a global investment bank in a series-A funding round totalling £5m net of costs. The funding will enable the company to advance the first two products based on its technology platform, for cartilage and ligament repair respectively, towards market approval.
Investindustrial sells its remaining stake of 4.12% in the company, fully exiting the investment
Following the deal, CCV Schweiz will be integrated with Concardis Schweiz, which is part of Nets Group
Minority shareholder IMS Capital has also filed for insolvency; Getnow is now seeking new investors
Exit from Rutland Fund III realises a return of 5.7x on the original cost of the investment